Research Paper Advance Articles
RGC32 promotes the progression of ccRCC by activating the NF-κB/SHP2/EGFR signaling pathway
Figure 3. Specific inhibition of RGC32 can inhibit the progression of ccRCC. (A) Results of tumor-bearing experiments and tumor volume statistics of 786-O cell nude mice; (B) The results of HE experiments in 786-O cells and the statistics of tumor slice area; (C) Results of tumor-bearing experiments and tumor volume statistics of ACHN cell nude mice; (D) The results of HE experiments in ACHN cells and the statistics of tumor slice area. **p < 0.01; nsp > 0.05.